Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel · Delayed Price · Currency is ILS · Price in ILA 131.30
+0.20 (0.15%)
At close: Jan 14, 2026
Novolog (Pharm-Up 1966) Revenue
Novolog (Pharm-Up 1966) had revenue of 483.59M ILS in the quarter ending September 30, 2025, a decrease of -12.22%. This brings the company's revenue in the last twelve months to 1.97B, up 4.89% year-over-year. In the year 2024, Novolog (Pharm-Up 1966) had annual revenue of 2.02B with 23.01% growth.
Revenue (ttm)
1.97B
Revenue Growth
+4.89%
P/S Ratio
0.34
Revenue / Employee
2.11M
Employees
936
Market Cap
669.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.02B | 378.11M | 23.01% |
| Dec 31, 2023 | 1.64B | 135.54M | 8.99% |
| Dec 31, 2022 | 1.51B | 252.70M | 20.13% |
| Dec 31, 2021 | 1.26B | 121.61M | 10.73% |
| Dec 31, 2020 | 1.13B | 129.51M | 12.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Ilex Medical | 917.10M |
| Kamada | 578.74M |
| SofWave Medical | 255.13M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
| Epitomee Medical | 37.17M |